Ironwood Pharmaceuticals Inc (IRWD) stock
IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3062% below fair value
$4.87+0.02 (+0.41%)
Close on Nov 17, 2026Market cap $804.72MP/E 6.3Yield –
Ironwood Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Ironwood Pharmaceuticals's cash was $79.13M at Jun 30, 2026. For fiscal 2025 it was $215.46M, up 143.3% from the year before. Over ten years it grew -2.2% a year on average. The highest annual figure on record is $656.20M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $215.46M | +143.3% |
| FY2024 | Dec 31, 2024 | $88.56M | -3.9% |
| FY2023 | Dec 31, 2023 | $92.15M | -86.0% |
| FY2022 | Dec 31, 2022 | $656.20M | +5.5% |
| FY2021 | Dec 31, 2021 | $621.86M | +70.5% |
| FY2020 | Dec 31, 2020 | $364.78M | +103.5% |
| FY2019 | Dec 31, 2019 | $179.24M | -0.9% |
| FY2018 | Dec 31, 2018 | $180.85M | -20.8% |
| FY2017 | Dec 31, 2017 | $228.47M | +267.0% |
| FY2016 | Dec 31, 2016 | $62.25M | -76.9% |
| FY2015 | Dec 31, 2015 | $270.03M | +263.5% |
| FY2014 | Dec 31, 2014 | $74.30M | -1.6% |
| FY2013 | Dec 31, 2013 | $75.49M | -44.8% |
| FY2012 | Dec 31, 2012 | $136.70M | +56.6% |
| FY2011 | Dec 31, 2011 | $87.28M | +96.9% |
| FY2010 | Dec 31, 2010 | $44.32M | -63.8% |
| FY2009 | Dec 31, 2009 | $122.31M | +84.4% |
| FY2008 | Dec 31, 2008 | $66.33M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $79.13M | -14.8% |
| Q1 FY2026 | Mar 31, 2026 | $220.47M | +103.2% |
| Q4 FY2025 | Dec 31, 2025 | $215.46M | +143.3% |
| Q3 FY2025 | Sep 30, 2025 | $140.41M | +59.2% |
| Q2 FY2025 | Jun 30, 2025 | $92.85M | -12.0% |
| Q1 FY2025 | Mar 31, 2025 | $108.48M | -10.7% |
| Q4 FY2024 | Dec 31, 2024 | $88.56M | -3.9% |
| Q3 FY2024 | Sep 30, 2024 | $88.21M | -19.9% |
| Q2 FY2024 | Jun 30, 2024 | $105.52M | -39.8% |
| Q1 FY2024 | Mar 31, 2024 | $121.54M | -83.6% |
| Q4 FY2023 | Dec 31, 2023 | $92.15M | -86.0% |
| Q3 FY2023 | Sep 30, 2023 | $110.16M | -80.8% |
| Q2 FY2023 | Jun 30, 2023 | $175.32M | -65.2% |
| Q1 FY2023 | Mar 31, 2023 | $740.34M | +24.8% |
| Q4 FY2022 | Dec 31, 2022 | $656.20M | +5.5% |
| Q3 FY2022 | Sep 30, 2022 | $574.19M | -0.0% |
| Q2 FY2022 | Jun 30, 2022 | $504.37M | +2.4% |
| Q1 FY2022 | Mar 31, 2022 | $593.37M | +35.3% |
| Q4 FY2021 | Dec 31, 2021 | $621.86M | +70.5% |
| Q3 FY2021 | Sep 30, 2021 | $574.28M | +86.7% |
| Q2 FY2021 | Jun 30, 2021 | $492.70M | +94.5% |
| Q1 FY2021 | Mar 31, 2021 | $438.47M | +89.7% |
| Q4 FY2020 | Dec 31, 2020 | $364.78M | +103.5% |
| Q3 FY2020 | Sep 30, 2020 | $307.56M | +120.9% |
| Q2 FY2020 | Jun 30, 2020 | $253.25M | +156.0% |
| Q1 FY2020 | Mar 31, 2020 | $231.14M | +94.2% |
| Q4 FY2019 | Dec 31, 2019 | $179.24M | -0.9% |
| Q3 FY2019 | Sep 30, 2019 | $139.23M | -13.7% |
| Q2 FY2019 | Jun 30, 2019 | $98.91M | -45.4% |
| Q1 FY2019 | Mar 31, 2019 | $119.05M | -38.8% |
| Q4 FY2018 | Dec 31, 2018 | $180.85M | -20.8% |
| Q3 FY2018 | Sep 30, 2018 | $161.40M | -0.8% |
| Q2 FY2018 | Jun 30, 2018 | $181.25M | -0.5% |
| Q1 FY2018 | Mar 31, 2018 | $194.45M | +45.9% |
| Q4 FY2017 | Dec 31, 2017 | $228.47M | +267.0% |
| Q3 FY2017 | Sep 30, 2017 | $162.64M | -11.1% |
| Q2 FY2017 | Jun 30, 2017 | $182.13M | – |
| Q1 FY2017 | Mar 31, 2017 | $133.32M | – |
| Q4 FY2016 | Dec 31, 2016 | $62.25M | – |
| Q3 FY2016 | Sep 30, 2016 | $182.94M | – |
See a number that looks wrong?